AI Assistant
Blog
Pricing
Log In
Sign Up
Induction of lymphokine-activated killer (LAK) activity by recombinant interleukin 2 in patients with hepatocellular carcinoma.
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
